Lu‐May Chiang

510 total citations
10 papers, 350 citations indexed

About

Lu‐May Chiang is a scholar working on Cardiology and Cardiovascular Medicine, Pharmacology and Complementary and alternative medicine. According to data from OpenAlex, Lu‐May Chiang has authored 10 papers receiving a total of 350 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Cardiology and Cardiovascular Medicine, 3 papers in Pharmacology and 3 papers in Complementary and alternative medicine. Recurrent topics in Lu‐May Chiang's work include Heart Failure Treatment and Management (3 papers), Complementary and Alternative Medicine Studies (3 papers) and Musculoskeletal pain and rehabilitation (3 papers). Lu‐May Chiang is often cited by papers focused on Heart Failure Treatment and Management (3 papers), Complementary and Alternative Medicine Studies (3 papers) and Musculoskeletal pain and rehabilitation (3 papers). Lu‐May Chiang collaborates with scholars based in United States, United Kingdom and Canada. Lu‐May Chiang's co-authors include Eric L. Hurwitz, Hal Morgenstern, Scott D. Solomon, John J.V. McMurray, Michael R. Zile, Brian Claggett, Margaret F. Prescott, Eileen O’Meara, Jean L. Rouleau and Gerald F. Kominski and has published in prestigious journals such as Blood, Journal of the American College of Cardiology and Spine.

In The Last Decade

Lu‐May Chiang

10 papers receiving 339 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lu‐May Chiang United States 8 160 115 56 49 45 10 350
Н. А. Шостак Russia 8 76 0.5× 69 0.6× 31 0.6× 38 0.8× 18 0.4× 115 309
Ye‐Hsu Lu Taiwan 11 162 1.0× 12 0.1× 39 0.7× 96 2.0× 17 0.4× 37 333
Lene Rørholm Pedersen Denmark 13 182 1.1× 35 0.3× 8 0.1× 94 1.9× 47 1.0× 18 462
Jah Yeon Choi South Korea 12 327 2.0× 20 0.2× 25 0.4× 194 4.0× 22 0.5× 76 528
Şule Arslan Türkiye 7 45 0.3× 33 0.3× 21 0.4× 66 1.3× 4 0.1× 11 283
Baanie Sawhney United States 10 74 0.5× 51 0.4× 50 0.9× 73 1.5× 5 0.1× 22 387
M. Fabregate Spain 8 39 0.2× 64 0.6× 90 1.6× 88 1.8× 4 0.1× 28 366
M Takahashi Japan 6 156 1.0× 13 0.1× 22 0.4× 97 2.0× 16 0.4× 18 369
Pang‐Yen Liu Taiwan 11 160 1.0× 10 0.1× 12 0.2× 35 0.7× 39 0.9× 41 343
Katarzyna Piestrzeniewicz Poland 11 187 1.2× 20 0.2× 10 0.2× 75 1.5× 12 0.3× 40 329

Countries citing papers authored by Lu‐May Chiang

Since Specialization
Citations

This map shows the geographic impact of Lu‐May Chiang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lu‐May Chiang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lu‐May Chiang more than expected).

Fields of papers citing papers by Lu‐May Chiang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lu‐May Chiang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lu‐May Chiang. The network helps show where Lu‐May Chiang may publish in the future.

Co-authorship network of co-authors of Lu‐May Chiang

This figure shows the co-authorship network connecting the top 25 collaborators of Lu‐May Chiang. A scholar is included among the top collaborators of Lu‐May Chiang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lu‐May Chiang. Lu‐May Chiang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Bocchi, Edimar Alcides, Luis Eduardo Echeverría, Caroline Demacq, et al.. (2024). Sacubitril/Valsartan Versus Enalapril in Chronic Chagas Cardiomyopathy. JACC Heart Failure. 12(8). 1473–1486. 1 indexed citations
2.
Čikeš, Maja, Ivo Planinc, Brian Claggett, et al.. (2022). Atrial Fibrillation in Heart Failure With Preserved Ejection Fraction. JACC Heart Failure. 10(5). 336–346. 27 indexed citations
3.
Suzuki, Kota, Brian Claggett, Masatoshi Minamisawa, et al.. (2021). Influence of study discontinuation during the run‐in period on the estimated efficacy of sacubitril/valsartan in the PARAGON‐HF trial. European Journal of Heart Failure. 23(12). 2085–2090. 7 indexed citations
4.
Cunningham, Jonathan W., Brian Claggett, Eileen O’Meara, et al.. (2020). Effect of Sacubitril/Valsartan on Biomarkers of Extracellular Matrix Regulation in Patients With HFpEF. Journal of the American College of Cardiology. 76(5). 503–514. 83 indexed citations
5.
6.
O’Meara, Eileen, Margaret F. Prescott, Jean L. Rouleau, et al.. (2016). Association between sST2 Levels and Cardiovascular Outcomes and Effect of Sacubitril/Valsartan on sST2 Levels: Results From the PARADIGM-HF Trial. Journal of Cardiac Failure. 22(8). S29–S30. 3 indexed citations
7.
8.
Hurwitz, Eric L., Michael S. Goldstein, Hal Morgenstern, & Lu‐May Chiang. (2006). The impact of psychosocial factors on neck pain and disability outcomes among primary care patients: Results from the UCLA Neck Pain Study. Disability and Rehabilitation. 28(21). 1319–1329. 34 indexed citations
9.
Hurwitz, Eric L., Hal Morgenstern, Gerald F. Kominski, Fei Yu, & Lu‐May Chiang. (2006). A Randomized Trial of Chiropractic and Medical Care for Patients With Low Back Pain. Spine. 31(6). 611–621. 61 indexed citations
10.
Hurwitz, Eric L. & Lu‐May Chiang. (2006). A comparative analysis of chiropractic and general practitioner patients in North America: Findings from the joint Canada/United States survey of health, 2002–03. BMC Health Services Research. 6(1). 49–49. 55 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Н. А. Шостак Breakdown of academic impact, for papers by Ye‐Hsu Lu Breakdown of academic impact, for papers by Lene Rørholm Pedersen Breakdown of academic impact, for papers by Jah Yeon Choi Breakdown of academic impact, for papers by Şule Arslan Breakdown of academic impact, for papers by Baanie Sawhney Breakdown of academic impact, for papers by M. Fabregate Breakdown of academic impact, for papers by M Takahashi Breakdown of academic impact, for papers by Pang‐Yen Liu Breakdown of academic impact, for papers by Katarzyna Piestrzeniewicz
Rankless by CCL
2026